How EKRA and AKS Impact Laboratories and Commission-Based Compensation
With the enactment of the Eliminating Kickbacks in Recovery Act in 2018, the permissibility of commission-based compensation to laboratory sales representatives based on volume, revenue, or profit has come under question, and there is still little case law interpreting the Act.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year